Schauder S, Mahrle G
Hautarzt. 1982 Apr;33(4):206-9.
Fifty-one patients with psoriasis were treated with 1% anthralin for 1 h (1-h treatment) and UV-light. Seven of 11 out-patients treated with anthralin and UV-B showed a good response. In 40 in-patients the 1-h regimen was administered in right-left side comparison to evaluate (1) whether UV-A or UV-B combined with anthralin was more effective than anthralin alone and (2) whether anthralin was photoactivated by UV-A or UV-B. As to the latter, one body side of the patients was exposed to UV radiation before and the other body side after application of anthralin. In in-patients the response to therapy was monitored by a defined score system. We did not find any significant differences in the paired comparisons. We therefore summarized the different treatment regimens and rated 42% with very good or good, 26% with fair, and 32% with poor. The results show that the 1-h treatment with 1% anthralin seems to be advantageous especially for the treatment of out-patients with circumscribed chronic psoriatic lesions. UV-light did not improve considerably the therapeutic effect of anthralin in the regimen of this study.
51例银屑病患者接受1%地蒽酚治疗1小时(1小时治疗)并联合紫外线照射。11例接受地蒽酚和UV - B治疗的门诊患者中有7例反应良好。在40例住院患者中,采用左右侧对照的方式进行1小时治疗方案,以评估:(1)UV - A或UV - B联合地蒽酚是否比单独使用地蒽酚更有效;(2)地蒽酚是否被UV - A或UV - B光激活。对于后者,患者身体的一侧在涂抹地蒽酚之前接受紫外线照射,另一侧在涂抹之后接受照射。对于住院患者,通过特定的评分系统监测治疗反应。在配对比较中我们未发现任何显著差异。因此,我们总结了不同的治疗方案,结果显示42%的患者治疗效果非常好或良好,26%的患者效果一般,32%的患者效果较差。结果表明,1%地蒽酚1小时治疗似乎具有优势,尤其适用于治疗患有局限性慢性银屑病皮损的门诊患者。在本研究方案中,紫外线照射并未显著提高地蒽酚的治疗效果。